SCHEMBL22079362

SCHEMBL22079362

CC(=O)Nc1ncc(CN2CCN(C(C)=O)CC2C)s1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ OGA O60502 19/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27100375 0.90 OGA (0.54) OGA
SCHEMBL22079723 0.87 OGA (0.64) OGA
SCHEMBL27022332 0.87 OGA (0.57) OGA
SCHEMBL27100348 0.85 OGA (0.71) OGA
SCHEMBL22432786 0.84 OGA (0.62) OGA
SCHEMBL30620432 0.83 OGA (0.73) OGA
SCHEMBL24862673 0.82 OGA (0.63) OGA
SCHEMBL22078760 0.82 OGA (0.51) OGA
SCHEMBL26373721 0.81 OGA (0.64) OGA
SCHEMBL22079707 0.81 OGA (0.57) OGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020117961-A1 MORPHOLINYL, PIPERAZINYL, OXAZEPANYL AND DIAZEPANYL O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS BIOGEN MA INC. (US) 2020-06-11 — — WO disclosed
Send feedback